AbbVie, Inc. (ABBV)
228.16
-1.32
(-0.58%)
USD |
NYSE |
Feb 24, 12:13
AbbVie Market Cap : 403.25B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 205.72B |
| Biogen, Inc. | 28.89B |
| Gilead Sciences, Inc. | 184.32B |
| Johnson & Johnson | 594.11B |
| Eli Lilly & Co. | 992.94B |
Market Cap Related Metrics
| PE Ratio | 96.62 |
| PS Ratio | 6.611 |
| Price to Free Cash Flow | 22.70 |
| Price | 228.16 |
| Earnings Yield | 1.03% |
| Operating PE Ratio | 20.15 |
| Normalized PE Ratio | 32.47 |